Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models. Prostate cancer and prostatic diseases Stavrinides, V., Papageorgiou, G., Danks, D., Giganti, F., Pashayan, N., Trock, B., Freeman, A., Hu, Y., Whitaker, H., Allen, C., Kirkham, A., Punwani, S., Sonn, G., Barratt, D., Emberton, M., Moore, C. M. 2021

View details for DOI 10.1038/s41391-021-00373-w

View details for PubMedID 33958731